HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹121 Cr | ₹414 Cr | ₹402 Cr | ₹285 Cr | ₹245 Cr |
What is the latest Capital Work in Progress ratio of HIKAL ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹402 Cr |
| Mar2022 | ₹285 Cr |
| Mar2021 | ₹245 Cr |
How is Capital Work in Progress of HIKAL Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹121 Cr | -70.75 | |
| Mar2024 | ₹414 Cr | 3.04 | |
| Mar2023 | ₹402 Cr | 40.99 | |
| Mar2022 | ₹285 Cr | 16.22 | |
| Mar2021 | ₹245 Cr | - | |
Compare Capital Work in Progress of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,529.5 Cr | -5.2% | -7.2% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -5.2% |
-7.2% |
-18% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses